Paper277233
The effect of misonidazole on the radiation response of clonogenic human pancreatic carcinoma cells.
Courtenay VD and 2 others. Br J Cancer Suppl, 1978. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. The effect of misonidazole on the radiation response of clonogenic human pancreatic carcinoma cells. Papers, record 277233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/277233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of misonidazole on the radiation response of clonogenic human pancreatic carcinoma cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nitroimidazoles | Major topic |
| Pancreatic Neoplasms | Major topic |
| Radiation-Sensitizing Agents | Major topic |
| Animals | |
| Cell Survival | |
| Humans | |
| Mice | |
| Neoplasm Transplantation | |
| Neoplasms, Experimental | |
| Oxygen | |
| Time Factors | |
| Transplantation, Heterologous |
Source PubMed
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 999782 | A colony-forming assay for human tumour xenografts using agar in diffusion chambers. | Br J Cancer | 1976 | https://conductscience.org/library/papers/999782 | PubMed |
| 2 | 995188 | In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. | Nature | 1976 | https://conductscience.org/library/papers/995188 | PubMed |
| 3 | 1276633 | Proceedings: An "in vitro" colony assay for human humours: radiation survival in a pancreatic tumour xenograft. | Br J Radiol | 1976 | https://conductscience.org/library/papers/1276633 | PubMed |
| 4 | 1156507 | The growth kinetics of xenografts of human colorectal tumours in immune deprived mice. | Br J Cancer | 1975 | https://conductscience.org/library/papers/1156507 | PubMed |
| 5 | 1125550 | In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique. | Br J Radiol | 1975 | https://conductscience.org/library/papers/1125550 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40789883 | Radiation activated photodynamic therapy (radioPDT) induces lipid peroxidation and vascular mediated tumor regression of prostate cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40789883 | PubMed |
| 7000122 | Analysis of tumour responses by excision and in vitro assay of cellular clonogenic capacity. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000122 | PubMed |
| 7000118 | Human tumour xenografts: a critical appraisal. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000118 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/277233
GET https://conductscience.org/api/papers/v1/277233/authors